NCT06567977 TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma Patients
| NCT ID | NCT06567977 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chiesi Poland Sp. z o.o. |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-08 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TriMaximize: A multicentre, prospective, non-interventional trial monitoring therapy pathways of asthma patients treated with an extra-fine ICS/LABA/LAMA single-inhaler triple therapy in a real-world setting and characterizing the effects on health-related outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 18 years of age, * Patients with confirmed leading diagnosis of asthma with or without concomitant COPD, * Physician decision to start fixed triple therapy with ICS/LABA/LAMA (Trimbow® MS or HS) according to its current authorised indication. The treatment decision must be made independently from participation in this NIS, * Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional study. Exclusion Criteria: • Participation in an interventional clinical trial within 30 days prior to en-rolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06567977 clinical trial?
This trial is open to participants of all sexes, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06567977 currently recruiting?
Yes, NCT06567977 is actively recruiting participants. Contact the research team at t.debowski@chiesi.com for enrollment information.
Where is the NCT06567977 trial being conducted?
This trial is being conducted at Tarnowskie Góry, Poland.
Who is sponsoring the NCT06567977 clinical trial?
NCT06567977 is sponsored by Chiesi Poland Sp. z o.o.. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.